A Mechanism for Cross-resistance to Nifurtimox and Benznidazole in Trypanosomes

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2008 Mar 28

PMID 18367671

Citations 181

Authors

Shane R Wilkinson

Martin C Taylor

David Horn

John M Kelly

Ian Cheeseman

Affiliations

Soon will be listed here.

Abstract

Nifurtimox and benznidazole are the front-line drugs used to treat Chagas disease, the most important parasitic infection in the Americas. These agents function as prodrugs and must be activated within the parasite to have trypanocidal effects. Despite >40 years of research, the mechanism(s) of action and resistance have remained elusive. Here, we report that in trypanosomes, both drugs are activated by a NADH-dependent, mitochondrially localized, bacterial-like, type I nitroreductase (NTR), and that down-regulation of this explains how resistance may emerge. Loss of a single copy of this gene in Trypanosoma cruzi, either through in vitro drug selection or by targeted gene deletion, is sufficient to cause significant cross-resistance to a wide range of nitroheterocyclic drugs. In Trypanosoma brucei, loss of a single NTR allele confers similar cross-resistance without affecting growth rate or the ability to establish an infection. This potential for drug resistance by a simple mechanism has important implications, because nifurtimox is currently undergoing phase III clinical trials against African trypanosomiasis.

Citing Articles

Repurposing COVID-19 Compounds (via MMV COVID Box): Almitrine and Bortezomib Induce Programmed Cell Death in .

Bethencourt-Estrella C, Lopez-Arencibia A, Lorenzo-Morales J, Pinero J Pathogens. 2025; 14(2).

PMID: 40005505 PMC: 11858128. DOI: 10.3390/pathogens14020127.

Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox.

Altcheh J, Grossmann U, Stass H, Springsklee M, Garcia-Bournissen F PLoS Negl Trop Dis. 2025; 19(2):e0012849.

PMID: 39999088 PMC: 11856279. DOI: 10.1371/journal.pntd.0012849.

In silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations.

Camargo P, da Silva R, Zuma A, Garden S, Albuquerque M, Rodrigues C Sci Rep. 2025; 15(1):6036.

PMID: 39971997 PMC: 11839977. DOI: 10.1038/s41598-025-90088-y.

System-based insights into parasitological and clinical treatment failure in Chagas disease.

Ernst L, Macedo G, McCall L mSystems. 2025; 10(2):e0003824.

PMID: 39772644 PMC: 11834445. DOI: 10.1128/msystems.00038-24.

Achieving the Optimal AgO Concentrations to Modulate the Anti- Activity of Ag-ZnO/AgO Nanocomposites: In Vivo Investigations.

Rodrigues do Carmo Neto J, Braga Y, Franco P, de Oliveira J, Trevisan R, Mendes K Pharmaceutics. 2024; 16(11).

PMID: 39598539 PMC: 11597568. DOI: 10.3390/pharmaceutics16111415.

References

Viode C, Bettache N, Cenas N, Krauth-Siegel R, Chauviere G, Bakalara N . Enzymatic reduction studies of nitroheterocycles. Biochem Pharmacol. 1999; 57(5):549-57. DOI: 10.1016/s0006-2952(98)00324-4. View

McCalla D, Reuvers A, Kaiser C . Mode of action of nitrofurazone. J Bacteriol. 1970; 104(3):1126-34. PMC: 248269. DOI: 10.1128/jb.104.3.1126-1134.1970. View

Nogoceke E, Gommel D, Kiess M, Kalisz H, Flohe L . A unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide metabolism in Crithidia fasciculata. Biol Chem. 1997; 378(8):827-36. DOI: 10.1515/bchm.1997.378.8.827. View

Docampo R . Sensitivity of parasites to free radical damage by antiparasitic drugs. Chem Biol Interact. 1990; 73(1):1-27. DOI: 10.1016/0009-2797(90)90106-w. View

Carnieri E, Moreno S, Docampo R . Trypanothione-dependent peroxide metabolism in Trypanosoma cruzi different stages. Mol Biochem Parasitol. 1993; 61(1):79-86. DOI: 10.1016/0166-6851(93)90160-y. View

Kubata B, Kabututu Z, Nozaki T, Munday C, Fukuzumi S, Ohkubo K . A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. J Exp Med. 2002; 196(9):1241-51. PMC: 2194105. DOI: 10.1084/jem.20020885. View

Raether W, Hanel H . Nitroheterocyclic drugs with broad spectrum activity. Parasitol Res. 2003; 90 Supp 1:S19-39. DOI: 10.1007/s00436-002-0754-9. View

Streeter A, Hoener B . Evidence for the involvement of a nitrenium ion in the covalent binding of nitrofurazone to DNA. Pharm Res. 1988; 5(7):434-6. DOI: 10.1023/a:1015988401601. View

McCalla D, Reuvers A, Kaiser C . Breakage of bacterial DNA by nitrofuran derivatives. Cancer Res. 1971; 31(12):2184-8. View

10.

Prathalingham S, Wilkinson S, Horn D, Kelly J . Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole. Antimicrob Agents Chemother. 2006; 51(2):755-8. PMC: 1797777. DOI: 10.1128/AAC.01360-06. View

11.

Wilkinson S, Prathalingam S, Taylor M, Ahmed A, Horn D, Kelly J . Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei. Free Radic Biol Med. 2006; 40(2):198-209. DOI: 10.1016/j.freeradbiomed.2005.06.022. View

12.

Crane F . Discovery of ubiquinone (coenzyme Q) and an overview of function. Mitochondrion. 2007; 7 Suppl:S2-7. DOI: 10.1016/j.mito.2007.02.011. View

13.

Filardi L, Brener Z . Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg. 1987; 81(5):755-9. DOI: 10.1016/0035-9203(87)90020-4. View

14.

Murta S, Gazzinelli R, Brener Z, Romanha A . Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol. 1998; 93(2):203-14. DOI: 10.1016/s0166-6851(98)00037-1. View

15.

Alsford S, Kawahara T, Glover L, Horn D . Tagging a T. brucei RRNA locus improves stable transfection efficiency and circumvents inducible expression position effects. Mol Biochem Parasitol. 2005; 144(2):142-8. PMC: 3833055. DOI: 10.1016/j.molbiopara.2005.08.009. View

16.

Parkinson G, Skelly J, Neidle S . Crystal structure of FMN-dependent nitroreductase from Escherichia coli B: a prodrug-activating enzyme. J Med Chem. 2000; 43(20):3624-31. DOI: 10.1021/jm000159m. View

17.

Moreno S, Mason R, Docampo R . Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase. J Biol Chem. 1984; 259(10):6298-305. View

18.

McCalla D, Kaiser C, Green M . Genetics of nitrofurazone resistance in Escherichia coli. J Bacteriol. 1978; 133(1):10-6. PMC: 221970. DOI: 10.1128/jb.133.1.10-16.1978. View

19.

Brandt U . Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem. 2006; 75:69-92. DOI: 10.1146/annurev.biochem.75.103004.142539. View

20.

Hirumi H, Hirumi K . Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol. 1989; 75(6):985-9. View